PubMed

Variation in the RAD51 gene and familial breast cancer.

Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

Breast Cancer Res. 2006;8(3):R26. Epub 2006 Jun 8.PMID: 16762046 [PubMed - indexed for MEDLINE]Related articlesFree article

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.

Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T.

Br J Cancer. 2004 May 17;90(10):2002-5.PMID: 15138485 [PubMed - indexed for MEDLINE]Related articlesFree article

RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.

Jara L, Acevedo ML, Blanco R, Castro VG, Bravo T, Gómez F, Waugh E, Peralta O, Cabrera E, Reyes JM, Ampuero S, González-Hormazábal P.

Cancer Genet Cytogenet. 2007 Oct 1;178(1):65-9.PMID: 17889711 [PubMed - indexed for MEDLINE]Related articles

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Górski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Am J Hum Genet. 2007 Dec;81(6):1186-200. Epub 2007 Oct 16.PMID: 17999359 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojć B, Nej K, Huzarska J, Byrski T, Górski B, Lubiński J.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):457-9.PMID: 12750242 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.

Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, Lin YH, Wu PE, Shen CY.

Carcinogenesis. 2009 Jan;30(1):43-9. Epub 2008 Oct 28.PMID: 18974064 [PubMed - indexed for MEDLINE]Related articlesFree article

BCoR-L1 variation and breast cancer.

Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB.

Breast Cancer Res. 2007;9(4):R54. Erratum in: Breast Cancer Res. 2008;10(5):406. PMID: 17697391 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.

Rapakko K, Heikkinen K, Karppinen SM, Winqvist R.

Cancer Lett. 2006 May 8;236(1):142-7. Epub 2005 Jul 11.PMID: 16005565 [PubMed - indexed for MEDLINE]Related articles

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.

Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiñski J, Scott RJ, Hamann U.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5.PMID: 17301259 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic instability in the RAD51 and BRCA1 regions in breast cancer.

Nowacka-Zawisza M, Bryś M, Romanowicz-Makowska H, Kulig A, Krajewska WM.

Cell Mol Biol Lett. 2007;12(2):192-205. Epub 2006 Dec 18.PMID: 17180310 [PubMed - indexed for MEDLINE]Related articles

Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.

Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, Kulig A, Krajewska WM.

Pathol Int. 2008 May;58(5):275-81.PMID: 18429825 [PubMed - indexed for MEDLINE]Related articles

BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.

Cousineau I, Abaji C, Belmaaza A.

Cancer Res. 2005 Dec 15;65(24):11384-91.PMID: 16357146 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of Rad51 alteration in patients with bilateral breast cancer.

Kato M, Yano K, Matsuo F, Saito H, Katagiri T, Kurumizaka H, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nagawa H, Nakamura Y, Miki Y.

J Hum Genet. 2000;45(3):133-7.PMID: 10807537 [PubMed - indexed for MEDLINE]Related articles

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin.

Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK.

J Biol Chem. 2000 Aug 4;275(31):23899-903.PMID: 10843985 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.

Blasiak J, Przybyłowska K, Czechowska A, Zadrozny M, Pertyński T, Rykała J, Kołacińska A, Morawiec Z, Drzewoski J.

Acta Biochim Pol. 2003;50(1):249-53.PMID: 12673366 [PubMed - indexed for MEDLINE]Related articlesFree article

Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.

Karppinen SM, Barkardottir RB, Backenhorn K, Sydenham T, Syrjäkoski K, Schleutker J, Ikonen T, Pylkäs K, Rapakko K, Erkko H, Johannesdottir G, Gerdes AM, Thomassen M, Agnarsson BA, Grip M, Kallioniemi A, Kere J, Aaltonen LA, Arason A, Møller P, Kruse TA, Borg A, Winqvist R.

J Med Genet. 2006 Nov;43(11):856-62. Epub 2006 Jul 6.PMID: 16825437 [PubMed - indexed for MEDLINE]Related articlesFree article

The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.

Söderlund K, Skoog L, Fornander T, Askmalm MS.

Radiother Oncol. 2007 Sep;84(3):242-51. Epub 2007 Aug 17.PMID: 17707537 [PubMed - indexed for MEDLINE]Related articles

Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.

Lewis AG, Flanagan J, Marsh A, Pupo GM, Mann G, Spurdle AB, Lindeman GJ, Visvader JE, Brown MA, Chenevix-Trench G; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

Breast Cancer Res. 2005;7(6):R1005-16. Epub 2005 Oct 21.PMID: 16280053 [PubMed - indexed for MEDLINE]Related articlesFree article

Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.

Romanowicz-Makowska H, Smolarz B, Kulig A.

Pol J Pathol. 2005;56(4):161-5.PMID: 16477874 [PubMed - indexed for MEDLINE]Related articles

Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.

Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J, Durocher F; INHERIT BRCAs.

J Hum Genet. 2008;53(7):579-91. Epub 2008 Apr 15.PMID: 18414782 [PubMed - indexed for MEDLINE]Related articles